|
|
| |
Glove Box Isolator |
| |
The
new JETPHARMA GLOVE BOX ISOLATOR is specifically developed and
manufactured in-house for the micronization of the Highly
Potent Active Pharmaceutical Ingredients, that provides
the maximum operator safety when working with toxic substances
meanwhile protecting the product from external contaminants.
The technology used for the new JETPHARMA GLOVE BOX ISOLATOR
comes from the nuclear industry and it has been studied to optimise
operator safety from the two primary means of exposure: namely
inhalation during the work process, and secondly, but potentially
more likely, inhalation during the disassembling and cleaning
phases of the equipment between trials.
To combat these shortcomings, JETPHARMA GLOVE BOX ISOLATOR can
operate at a constant negative pressure. The airflow from exterior
to interior is regulated to create the constant negative pressure
within the range of 5-25 mmH2OC in the working area, and small
DP of a few mmH2OC to create an airlock in the transfer area.
Horizontal and vertical currents draw any released particles
within the working area to the filtration unit comprised of
pre-filtration and absolute (HEPA) filters. Once filtered, the
air is partially recycled to the working area, with make-up
air supplied externally to avoid build-up of impurities and/or
humidity. All components in contact with the product can be
washed inside the isolator. It is possible to work, depending
upon the requirements to protect the operator from the product,
or to protect the product from the external contamination. To
protect the product from contaminates, the JETPHARMA GLOVE BOX
ISOLATOR can work at positive pressure to maintain a class 100
working environment for sterile applications.
The flexibility offered by JETPHARMA's new glove box solution
to work in either a range of constant negative pressure from
5 to 40 mmH20C, or in a range of constant positive pressure
from 2 to 20 mmH2OC allows the design to function for a variety
micronization requirements.
www.isolationsolutions.com
|
|
|
